MedPath
NMPA Approval

石淋通颗粒

国药准字Z44021724

August 7, 2019

Drug Information

石淋通颗粒

白云山

颗粒剂

每袋装15g(相当于总药材15g)

中药

August 7, 2019

Company Information

Manufacturing Company

广州市沙太北路389号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

石淋通颗粒 - NMPA 批准文号 | MedPath